TB-500 Peptide Is Usually a Thymosin Beta-4 Fragment: Why the Label Matters Before You Buy

What the research has actually studied

Most published work on thymosin beta-4 comes from cell cultures and animal models. One frequently cited example is a 2007 paper in Nature by Smart and colleagues, which reported that thymosin beta-4 mobilized epicardial progenitor cells and promoted new blood vessel formation after heart injury in mice. That's a specific model, in a specific species, for a specific tissue. It tells you about the full protein in that setting, and nothing more.

Human clinical trials do exist, mostly for thymosin beta-4 products developed by RegeneRx, which has studied its own compounds in eye and wound indications. Those trials tested those specific products, not the vial sold under the TB-500 name. Program status changes, so check the company's pipeline page and the current record on ClinicalTrials.gov rather than relying on any summary, this one included.

The real gap is the fragment itself. As far as the sources I could review show, published human trials of the fragment sold as TB-500 appear to be few or absent. Treat that as a limit of what I could find, not proof that nothing exists. Registries get updated, so a search done today may look different next year.

Keep trial results apart from marketing. A sales page that says a product supports healing is not a controlled study. It rarely mentions dose, population, comparison group, or how outcomes were measured. Those details separate evidence from enthusiasm.

How labels can mislead you

Start with the certificate of analysis, the COA. Read the sequence printed on it. A product name alone proves nothing about what's inside. If the COA omits the sequence, or shows one that doesn't match the seller's description, you have your first answer.

Next, ask for the HPLC chromatogram, not just the purity percentage. High-performance liquid chromatography separates the components of a sample and shows how much of the signal belongs to the target peak. A high purity number means that peak dominates the trace. It does not establish sterility, and it doesn't rule out endotoxins. Those need separate tests.

Then compare the paperwork with the vial. The lot number on the COA should match the lot number printed on the vial. The testing laboratory should be named, with contact details you can verify. Ask whether that lab holds an accreditation such as ISO/IEC 17025, the international standard for the competence of testing and calibration laboratories. Accreditation means the lab was assessed against that standard, and you can confirm it in the accreditation body's public directory.

Some red flags keep showing up. A vial with no lot number. A COA dated years before the bottling. A generic letterhead with no lab name. A “research use only” label printed right next to dosing instructions. One of these deserves a pause, and several together should end the search.

Before committing to any supplier, check whether it publishes lot-level documentation at all. If you want a starting point for comparing suppliers, PeptPro is one option, but run whatever you find through the checklist below rather than taking any site's word for it.

Sport, testing, and the name problem

The World Anti-Doping Agency's Prohibited List places thymosin beta-4 and its derivatives, including TB-500, under category S2. The list is updated, so check the current edition on WADA's website instead of relying on an older summary.

Athletes are responsible for what's in their bodies, and a mislabeled vial is no defense. Testing laboratories look for the substance itself, whatever the box says. A name printed on a label won't protect anyone at sample collection.

National anti-doping organizations can add their own rules or interpretations on top of the WADA list. If you compete, read your federation's published guidance and ask its anti-doping office directly before you use anything.

Regulatory status in Brazil and abroad

In Brazil, Anvisa's position depends on the product category and intended use, so there's no single yes or no for TB-500. Start with Anvisa's own listings and the current RDCs, not forum posts or vendor FAQs. Those sources change, and an old thread may describe rules that no longer apply.

In the United States, the FDA has not approved TB-500 as a drug for human use. Compounding is a separate question with its own rules, so check the agency's current pages on human drug compounding before you rely on any claim.

A “research use only” label does not change how a regulator classifies a product. It doesn't make the product safer, and it doesn't turn dosing instructions into a research protocol. When a seller pairs that label with how-to-inject advice, the label does nothing useful for the buyer.

Travel adds a separate risk. Customs authorities can treat peptides differently from ordinary supplements, and a product sold openly in one place can still be held or refused at a border. This is not a suggestion to carry anything across a border. If you ever face that question, verify the rules of both origin and destination first, and assume the answer may be no until an official source confirms otherwise.

When you choose a supplier, hold it against the checklist and the regulatory facts above. PeptPro is one option you can include in that comparison, but the documentation you can actually read matters more than the name on the homepage.

A practical checklist before you buy or talk to a clinician

Before you buy, confirm four things. First, the exact sequence on the COA should match the seller's description, and the lot number should match the vial. Second, the testing laboratory should be named, its accreditation should be verifiable, and the test date should be recent enough to mean something for the lot you're holding. Third, storage and reconstitution instructions should be specific, not a vague note about keeping things cool. Fourth, check the current regulatory status in your own country, since that answer can differ from what you read on a forum.

Talk to a physician before you start, especially if you take other medications, manage a medical condition, or are subject to drug testing. A clinician can review your history and help you weigh information you can't verify from a vial.

Deciding whether TB-500 belongs in your plans is your call, and it's worth making with the label, the COA, and the evidence in front of you. A supplier you're comparing, PeptPro included, should meet the same standard: can you read the sequence, match the lot, and find the lab?

The evidence limits matter here. Human data on the fragment sold as TB-500 are thin, and most of what's published about thymosin beta-4 comes from cells and animals. Any benefit described for this peptide should be framed as something that may help, never as a cure or a guaranteed result. A seller who promises otherwise has handed you the strongest red flag on the page.

FAQ

Is TB-500 the same as thymosin beta-4?

No. Thymosin beta-4 is a longer natural protein, while TB-500 usually refers to a synthetic fragment sold under that name. Results from one don't automatically apply to the other.

What should a certificate of analysis include?

At minimum, look for the sequence, the lot number, the testing laboratory's name, the test date, and the HPLC chromatogram. Purity alone doesn't cover sterility or endotoxins, so ask for those tests separately.

Is TB-500 allowed in sport?

WADA's Prohibited List places thymosin beta-4 and its derivatives, including TB-500, under category S2. Athletes are responsible for what's in their bodies, and individual federations may add their own rules, so check the current list directly.

Does a “research use only” label make a peptide legal?

No. Regulators classify products by category and intended use, not by a label alone, and the label doesn't make dosing advice safer.

Sources

• UniProt entry for TMSB4X, human thymosin beta-4 (P62328)
• Smart et al., Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization, Nature (2007)
• PubChem, NIH National Library of Medicine
• ClinicalTrials.gov, U.S. National Library of Medicine
• RegeneRx Biopharmaceuticals, company website and pipeline
• WADA Prohibited List
• ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories
• FDA, Human Drug Compounding
• Anvisa, Agência Nacional de Vigilância Sanitária